Athira Pharma's stock plummets after disappointing drug trial results

Published on 22 Jun 2022 on American City Business Journals

Stock of Bothell-based biotech Athira Pharma Inc. (Nasdaq: ATHA) tumbled more than 66% Wednesday...

Read the rest of the article

Start tracking your investments with Statfolio

Investors interested in Medical stocks should always be looking to find the best-performing compa...

Zacks via Yahoo Finance 29 Mar 2024

Momentum investing is all about the idea of following a stock's recent trend, which can be in eit...

Zacks via Yahoo Finance 28 Feb 2024

Generally, when a single insider buys stock, it is usually not a big deal. However, when several ...

Simply Wall St. via Yahoo Finance 15 Nov 2023

The price trend for Athira Pharma, Inc. (ATHA) has been bearish lately and the stock has lost 10....

Zacks via Yahoo Finance 29 Aug 2023

Shares of ImmunityBio IBRX were down 55.1% on Thursday after management announced that FDA issued...

Zacks via Yahoo Finance 12 May 2023

Novavax, Inc. NVAX incurred a loss of $3.41 per share for first-quarter 2023, which was wider tha...

Zacks via Yahoo Finance 10 May 2023

Key Insights Given the large stake in the stock by institutions, Athira Pharma's stock price migh...

Simply Wall St. via Yahoo Finance 29 Apr 2023

Athira Pharma, Inc. (ATHA) could be a solid addition to your portfolio given its recent upgrade t...

Zacks via Yahoo Finance 28 Mar 2023

Leen Kawas resigned as Athira's CEO in October 2021 after an investigation into her doctoral work...

American City Business Journals 21 Jan 2023

Leen Kawas was the face of Athira Pharma before allegations of altered images in her doctoral wor...

American City Business Journals 21 Jan 2023